Alpha-1 Foundation: Postdoctoral Research Fellowship Grant

The Alpha-1 Foundation's Postdoctoral Research Fellowship aims to support early-career researchers focusing on Alpha-1 Antitrypsin Deficiency. With a maximum funding of $75,000 per year for up to two years, this program seeks to foster clinical and basic science research. Applicants should hold relevant degrees and commit at least 50% of their time to AAT-related studies, while also budgeting for essential travel to the Foundation's Biennial Investigators' Meeting.

Grants Awards Program
The Grants Award Program is the Alpha-1 Foundation’s mechanism to fund a broad range of research that leads to improvements in the lives of people living with AAT Deficiency.
Goals
The specific goals of the Program are:
to promote basic science and clinical research related to the alpha-1 antitrypsin protein and AAT Deficiency;to attract and train clinical researchers for the study of AAT Deficiency;to support and encourage established scientists to work on clinical problems and ethical, legal, and social issues within the field of AAT research (with a preference given to new investigators); and ultimately,to develop effective therapies for the clinical manifestations of AAT Deficiency.
The Alpha-1 Foundation will support a broad spectrum of research projects involving basic science, translational and clinical research, and ethical, legal, and social issues.
The objective of this grant is to provide support for postdoctoral research fellows who are starting their research careers and are working in the laboratories of established researchers or conducting research with the mentorship of established researchers. In addition, this grant category is intended to provide support for postdoctoral research fellows who intend to pursue a career in AAT research.
Objective
Support postdoctoral research fellows starting their research careers in laboratories of established researchers or those conducting research under AATD senior researchers.
Funding
Maximum of $75,000 per year may be requested. Up to 2 years of support is available.

Eligibility

Applications will be accepted from candidates holding an M.D., Ph.D. or equivalent degrees who are interested in conducting basic science, clinical research, or ethic, legal, social issues studies related to AAT Deficiency. Applicants must indicate a commitment to AAT-related research by focusing 50% of their time to AAT Deficiency research or clinical practice. The Alpha-1 Foundation requires that each applicant allocate $1,000 of the total budget to pay for travel to the Alpha-1 Foundation’s Biennial Investigators’ Meeting for the first year of the proposal’s period of performance. In case the applicant cannot attend the Investigators’ Meeting, the $1,000 budgetary line item is not refundable.

Ineligibility

Please note that the Alpha-1 Foundation does not accept LOIs or grant applications from pharmaceutical companies, biotechs, or industry for its in-cycle grants programs. These entities may not be collaborators on any proposals.  Any individual who received an Alpha-1 Foundation Research Grant in the previous year’s grant cycle is not eligible to apply for an in-cycle grant in the current cycle. Major equipment may not be requested as part of a grant application, in accordance with Alpha-1 Foundation policies. Major equipment is defined as equipment that costs more than $500.The Alpha-1 Foundation does not pay for indirect costs, facilities and administrative costs or overhead costs.